Dr. Erin M. Bertino, MD

  • Westerville, OH
  • Hematologist and oncologist
NPI1043355688PAC ID7012015381
Medicare services, 2024
2,228
Medicare patients, 2024
244
Part D claims, 2024
748
Publications
41
Clinical trials
10
Practice address
300 Polaris Pkwy, Westerville, OH 43082
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Polaris Surgery Center - HOPD

Acute Care Hospital outpatient department · Westerville, Ohio

See all 14 affiliations

Find Dr. Bertino's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Erin M. Bertino is a hematologist and oncologist in Westerville, Ohio

Dr. Bertino practices at Polaris Surgery Center - HOPD in Westerville, Ohio.

Dr. Bertino's NPI, 1043355688, was assigned on February 21, 2007. Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004. Dr. Bertino holds Ohio license 35.088851.

NPI and contact details
Medicare PAC ID
7012015381
NPI enumeration date
February 21, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
48
Medical school graduation
2004

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Erin M. Bertino practices at Polaris Surgery Center - HOPD in Westerville, Ohio

Dr. Bertino's primary practice is Polaris Surgery Center - HOPD, at 300 Polaris Pkwy, Westerville, OH 43082.

  • Polaris Surgery Center - HOPD
    300 Polaris Pkwy, Westerville, OH 43082

Source: Dmand AI Affiliation Data

Dr. Erin M. Bertino is affiliated with 10 sites of care and 4 medical groups

Dr. Bertino's primary practice is Polaris Surgery Center - HOPD in Westerville, Ohio. Dr. Bertino is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Bertino to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 2 ambulatory surgery centers, each named with a free account.

See all 14 affiliations for Dr. Bertino

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Erin M. Bertino's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bertino practices, 10 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Polaris Surgery Center - HOPDAvailable with a free account
+9 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bertino practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Erin M. Bertino is one of 460 hematologists and oncologists in Ohio

Hematology and oncology is Dr. Bertino's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bertino is licensed in Ohio.

Specialties and state licenses

  • Hematology and oncology, OhioPrimaryLicense 35.088851 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Bertino

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

460hematologists and oncologists in Ohio
4hematologists and oncologists in Westerville

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Erin M. Bertino billed Medicare for 2,228 services in 2024

CMS data shows 2,228 Medicare services from Dr. Bertino across 21 procedure codes in 2024, for 244 Medicare patients. Medicare paid $80,441 for them.

Medicare services, 20242,228
Medicare patients244
Paid by Medicare$80,441
Procedure codes21

Dr. Bertino's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 2702024: 1,104309%
Other services
2023: 02024: 407
Office and hospital visits
2023: 3292024: 36110%
Tests and treatments
2023: 1242024: 356187%

Where Dr. Bertino's Medicare services took place, 2024

  • In an office2,18398%
  • In a facility452%

Dr. Bertino compared with the Ohio median for hematologists and oncologists, 2024

  • Dr. Bertino
  • Ohio median
Medicare services
2,228vs 6263.6 times
Medicare patients
244vs 234Close to median
Part D claims
460vs 478Close to median

Medians across 452 hematologists and oncologists in Ohio with Dmand AI profiles that report each measure.

Dr. Bertino's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bertino

Need commercial claims for Dr. Bertino?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bertino and other hematologists and oncologists in Ohio.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Erin M. Bertino treated 244 Medicare patients in 2024, average age 74

CMS counts 244 Medicare patients who saw Dr. Bertino in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bertino's median patient age at 68, with 65% women.

Medicare patients, 2024244
Average age74
Average risk score1.98

Dr. Bertino's Medicare patients by age, 2024

Dr. Bertino's Medicare patients by sex, 2024

  • Women14258%
  • Men10242%

Chronic conditions among Dr. Bertino's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol73%
  3. Arthritis48%
  4. Cancer47%
  5. Chronic kidney disease32%
  6. Diabetes32%
  7. Ischemic heart disease32%
  8. Anxiety31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bertino's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women65%
  • Men34%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Erin M. Bertino wrote 748 Medicare Part D claims in 2024

In 2024, Dr. Bertino wrote 748 Medicare Part D claims for 132 patients. 87% of them were for generic drugs. CMS names the drug for 460 of them, across 17 drugs with 11 or more claims each, at $358,974 in total drug cost. In 2023, CMS named 462 claims across 17 drugs.

Part D claims, 2024748
Drugs named by CMS17
Total drug cost$358,974
Part D patients132

Dr. Bertino's Part D claims by kind of drug, 2024

  • Generic649 claims87%
  • Brand-name and other99 claims13%

Dr. Bertino's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bertino's Part D claims, 2024

  • Opioids9%64 of 748 claims
  • Antibiotics7%53 of 748 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4622024: 460No change

Drugs named by CMS: 17 in 2024, 17 in 2023.

See all prescribing by Dr. Bertino

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Erin M. Bertino offers telehealth to Medicare patients

Dr. Bertino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bertino as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Bertino by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Erin M. Bertino has 41 publications on record

Dmand AI links 41 papers to Dr. Bertino, published from 2011 to 2024. 2017 was the busiest year, with 5. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Bertino has published most often in Lung Cancer. Dr. Bertino's most frequent co-authors are Gregory A. Otterson, MD, David Paul Carbone, MD, PhD and Peter Gary Shields, MD.

Papers41
Years published2011 to 2024

Dr. Bertino's papers by year, 2015 to 2024

Topics Dr. Bertino writes about most

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Palliative Care
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Protein Kinase Inhibitors

Dr. Bertino's most frequent co-authors

Recent publications by Dr. Bertino

See all 41 publications and co-authors

See who Dr. Bertino researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bertino works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Erin M. Bertino has worked on 10 clinical trials

Dmand AI links Dr. Bertino to 10 clinical trials, 5 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Lung Neoplasms, Thoracic Neoplasms and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 5.

Clinical trials with Dr. Bertino by phase

  1. 1Phase 1: 1 trial
  2. 5Phase 2: 5 trials
  3. 1Phase 2/3: 1 trial
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Bertino's trials

  • Lung Neoplasms
  • Thoracic Neoplasms
  • Adenocarcinoma of Lung
  • Rectal Diseases
  • Thyroid Neoplasms

Investigators on the most trials with Dr. Bertino

Recent clinical trials with Dr. Bertino

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Erin M. Bertino received $80,310 in industry payments from 2017 to 2025

CMS Open Payments shows 66 general payments to Dr. Bertino from 13 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Pfizer Inc. paid the most, $45,321.

General payments to Dr. Bertino by program year, 2017 to 2025

General payments to Dr. Bertino by kind, 2017 to 2025

$80.3Kin total
  • Speaker and faculty fees$45,51957%
  • Consulting fees$26,39633%
  • Travel and lodging$6,4588%
  • Food and beverage$1,8842%
  • Education$530%

Companies that paid Dr. Bertino the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Bertino

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Erin M. Bertino graduated from Northeastern Ohio University College of Medicine

Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004.

  1. Medical schoolNortheastern Ohio University College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Erin M. Bertino's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Erin M. Bertino

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Erin M. Bertino's NPI number?

Dr. Erin M. Bertino's NPI number is 1043355688. It was assigned on February 21, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Erin M. Bertino?

Dr. Erin M. Bertino is a hematologist and oncologist in Westerville, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Erin M. Bertino practice?

Dr. Bertino practices at 300 Polaris Pkwy, Westerville, OH 43082. Dr. Bertino's primary practice is Polaris Surgery Center - HOPD in Westerville, Ohio. Dmand AI also links Dr. Bertino to 3 hospitals, 3 group practices and clinics, 3 medical groups and 2 ambulatory surgery centers.

What is Dr. Erin M. Bertino's medical license number?

Dr. Bertino holds Ohio license 35.088851.

Which hospitals is Dr. Erin M. Bertino affiliated with?

Dr. Bertino is affiliated with OhioHealth Riverside Methodist Hospital. Dmand AI links Dr. Bertino to 3 more hospitals.

What medical group is Dr. Erin M. Bertino part of?

Dr. Bertino is linked to OhioHealth Physician Group. Dmand AI links Dr. Bertino to 3 more medical groups.

Does Dr. Erin M. Bertino accept Medicare?

Yes. CMS data shows Dr. Bertino billed Medicare for 2,228 services in 2024, and Dr. Bertino accepts Medicare assignment.

Does Dr. Erin M. Bertino offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Bertino as offering telehealth services.

How many Medicare patients does Dr. Erin M. Bertino see?

CMS counts 244 Medicare patients who saw Dr. Bertino in 2024, with an average age of 74.

What services does Dr. Erin M. Bertino bill to Medicare?

In 2024, Dr. Bertino's most billed Medicare services were injected or infused drug (J1100), injected or infused drug (J2469) and medicare temporary code (Q5111).

Show 6 more questionsShow fewer questions

Where did Dr. Erin M. Bertino go to medical school?

Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004.

What drugs does Dr. Erin M. Bertino prescribe most?

In 2024 Medicare Part D data, Dr. Bertino's most prescribed drugs by claims were Anastrozole, Letrozole and Dexamethasone.

Has Dr. Erin M. Bertino received payments from drug or device companies?

CMS Open Payments shows $80,310 in general payments to Dr. Bertino from 13 companies from 2017 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Erin M. Bertino been practicing?

Dr. Bertino graduated from medical school in 2004, 22 years ago.

Does Dr. Erin M. Bertino do research?

Dmand AI links 41 publications to Dr. Bertino, published from 2011 to 2024. Dr. Bertino has worked on 10 clinical trials.

Who does Dr. Erin M. Bertino publish with?

Dr. Bertino's most frequent co-authors are Gregory A. Otterson, MD (21 shared papers), David Paul Carbone, MD, PhD (13 shared papers) and Peter Gary Shields, MD (10 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Ohio by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)